About ImmuneHealth
ImmuneHealth is a Healthcare company based in Charleroi (Belgium) founded in 2007, and was acquired by CellCarta in September 2016. Service provider in biomarker research. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services.
Company details
Immune health is a biomarker discovery clinical research organization. It offers services in clinical testing, biomarker development, assay development, and immune testing which included designing, setting up and conduct prospective clinical studies on various types of human biospecimens (PBMC, blood, urine, saliva, biopsies, etc.) using immunoassays as diverse as ELISA, ELISpot, Multiplex, rt(q)PCR, sequencing, pyrosequencing, flow cytometry, microneutralization, and CAPS. The Immuno testing division of the company got acquired by Caprion Biosciences in September 2016 and the company retained clinical testing and biomarker division.
- Headquarters Charleroi, Belgium
- Stage Acquired
- SectorsHealthcare
- Website immunehealth.eu
- Social LinkedIn
- Acquired by CellCarta (Sep 2016)
Investors in ImmuneHealth
ImmuneHealth has secured backing from 1 investor. Prominent investors backing the company include CellCarta.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Histopathology and genomics services are offered by the CRO. | 2000 | cellcarta.com | Montreal, Canada |
Investor details for ImmuneHealth
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ImmuneHealth
2 dated milestones of ImmuneHealth across 9 years, from founding to its latest funding, stage changes and deals.
- Founded ImmuneHealth is founded.
- Exit Acquired by CellCarta.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ImmuneHealth
ImmuneHealth was founded in 2007.
ImmuneHealth is headquartered in Charleroi, Belgium. It is registered at Charleroi, Walloon Region, Belgium.
Immune health is a biomarker discovery clinical research organization. It offers services in clinical testing, biomarker development, assay development, and immune testing which included designing, setting up and conduct prospective clinical studies on various types of human biospecimens (PBMC, blood, urine, saliva, biopsies, etc.) using immunoassays as diverse as ELISA, ELISpot, Multiplex, rt(q)PCR, sequencing, pyrosequencing, flow cytometry, microneutralization, and CAPS. The Immuno testing division of the company got acquired by Caprion Biosciences in September 2016 and the company retained clinical testing and biomarker division.
ImmuneHealth has 1 investor. Key investors include CellCarta.
Yes. ImmuneHealth was acquired by CellCarta in September 2016.